New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
Cosío
Francisco G
FG
Delpón
Eva
E
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D001282:Atrial Flutter / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008955:Models, Cardiovascular; D009431:Neural Conduction / Q000187:drug effects; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D026941:Sodium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D026941:Sodium Channel Blockers